Phosphorylation of PRAS40-Thr246 involved in renal lipid accumulation of diabetes

Journal of Cellular Physiology

Volumn 229, Issue 8, 2014, Pages 1069-1077

  Hao, Jun ^a   Li, Fan ^a   Liu, Wei ^a   Liu, Qingjuan ^a   Liu, Shuxia ^a   Li, Hongbo ^a   Duan, Huijun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ADIPOPHILIN; FAT DROPLET; GLUCOSE; INSULIN; PRAS40 PROTEIN; PROTEIN; PROTEIN KINASE B; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THR246 PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HYPERGLYCEMIA; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSULIN TREATMENT; KIDNEY; KIDNEY TUBULE CELL; LIPID METABOLISM; LIPID STORAGE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; UPREGULATION; WESTERN BLOTTING;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID SEQUENCE; ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; INSULIN; KIDNEY; LIPID METABOLISM; MALE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84899098781     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24533     Document Type: Article

References (22)

1. Brown MS, Goldstein JL. 1997. The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 89:331-340.
2. Chong ZZ, Shang YC, Wang S, Maiese K. 2012. PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection. PLoS ONE 7:e45456.
3. Das F, Dey N, Venkatesan B, Kasinath BS, Ghosh-Choudhury N, Choudhury GG. 2011. High glucose upregulation of early-onset Parkinson's disease protein DJ-1 integrates the PRAS40/TORC1 axis to mesangial cell hypertrophy. Cell Signal 23:1311-1319.
4. Dey N, Ghosh-Choudhury N, Das F, Li X, Venkatesan B, Barnes JL, Kasinath BS, Ghosh Choudhury G. 2010. PRAS40 acts as a nodal regulator of high glucose-induced TORC1 activation in glomerular mesangial cell hypertrophy. J Cell Physiol 225:27-41.
5. Dituri F, Mazzocca A, Giannelli G, Antonaci S. 2011. PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors. Clin Dev Immunol 2011:947858.
6. Folch J, Lees M, Sloane Stanley GH. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509.
7. Hao J, Liu S, Zhao S, Liu Q, Lv X, Chen H, Niu Y, Duan H. 2011a. PI3K/Akt pathway mediates high glucose-induced lipogenesis and extracellular matrix accumulation in HKC cells through regulation of SREBP-1 and TGF-beta1. Histochem Cell Biol 135:173-181.
8. Hao J, Zhu L, Zhao S, Liu S, Liu Q, Duan H. 2011b. PTEN ameliorates high glucose-induced lipid deposits through regulating SREBP-1/FASN/ACC pathway in renal proximal tubular cells. Exp Cell Res 317:1629-1639.
9. Jackel-Cram C, Qiao L, Xiang Z, Brownlie R, Zhou Y, Babiuk L, Liu Q. 2010. Hepatitis C virus genotype-3a core protein enhances sterol regulatory element-binding protein-1 activity through the phosphoinositide 3-kinase-Akt-2 pathway. J Gen Virol 91:1388-1395.
10. Jun H, Song Z, Chen W, Zanhua R, Yonghong S, Shuxia L, Huijun D. 2009. In vivo and in vitro effects of SREBP-1 on diabetic renal tubular lipid accumulation and RNAi-mediated gene silencing study. Histochem Cell Biol 131:327-345.
11. Kim JB, Spotts GD, Halvorsen YD, Shih HM, Ellenberger T, Towle HC, Spiegelman BM. 1995. Dual DNA binding specificity of ADD1/SREBP1 controlled by a single amino acid in the basic helix-loop-helix domain. Mol Cell Biol 15:2582-2588.
12. Kovacina KS, Park GY, Bae SS, Guzzetta AW, Schaefer E, Birnbaum MJ, Roth RA. 2003. Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J Biol Chem 278:10189-10194.
13. Li Y, Xu S, Mihaylova MM, Zheng B, Hou X, Jiang B, Park O, Luo Z, Lefai E, Shyy JY, Gao B, Wierzbicki M, Verbeuren TJ, Shaw RJ, Cohen RA, Zang M. 2011. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab 13:376-388.
14. Nascimento EB, Fodor M, van der Zon GC, Jazet IM, Meinders AE, Voshol PJ, Vlasblom R, Baan B, Eckel J, Maassen JA, Diamant M, Ouwens DM. 2006. Insulin-mediated phosphorylation of the proline-rich Akt substrate PRAS40 is impaired in insulin target tissues of high-fat diet-fed rats. Diabetes 55:3221-3228.
15. Park CY, Jun HJ, Wakita T, Cheong JH, Hwang SB. 2009. Hepatitis C virus nonstructural 4B protein modulates sterol regulatory element-binding protein signaling via the AKT pathway. J Biol Chem 284:9237-9246.
16. Proctor G, Jiang T, Iwahashi M, Wang Z, Li J, Levi M. 2006. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 55:2502-2509.
17. Sancak Y, Thoreen CC, Peterson TR, Lindquist RA, Kang SA, Spooner E, Carr SA, Sabatini DM. 2007. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell 25:903-915.
18. Satirapoj B. 2012. Nephropathy in diabetes. Adv Exp Med Biol 771:107-122.
19. Sun L, Halaihel N, Zhang W, Rogers T, Levi M. 2002. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 277:18919-18927.
20. Wada J, Makino H. 2013. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci (Lond) 124:139-152.
21. Yuan M, Pino E, Wu L, Kacergis M, Soukas AA. 2012. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2. J Biol Chem 287:29579-29588.
22. Zhao S, Zhu L, Duan H, Liu S, Liu Q, Liu W, Hao J. 2012. PI3K/Akt pathway mediates high glucose-induced lipid accumulation in human renal proximal tubular cells via spliced XBP-1. J Cell Biochem 113:3288-3298.